Solve GNE, a nonprofit foundation dedicated to accelerating treatments for GNE myopathy, has announced major progress across its research, fundraising, and regulatory efforts. To date, the non-profit ...
Please provide your email address to receive an email when new articles are posted on . 47.5% of patients treated with glucocorticoids reported myopathy. Cumulative dosage, age, sex and weight were ...
This report describes a female patient in her 60s with an immune-mediated necrotising myopathy (IMNM) occurring after semaglutide use. She was found to have progressive dysphagia, dysphonia, proximal ...